- Effectively treats acne vulgaris
- The only topical erythromycin gel on the market
- Provides convenient, spreadable coverage
- Used once or twice a day for 6 to 8 weeks
IMPORTANT SAFETY INFORMATION
Full Prescribing Information
ERYGEL®(Erythromycin) Topical Gel USP, 2% is contraindicated in individuals who have shown hypersensitivity to any of its components.
Pseudomembranous colitis has been reported with nearly all antibacterial agents, including erythromycin and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with diarrhea subsequent to administration of antibacterial agents.
ERYGEL is for topical use only, not for ophthalmic use. Avoid contact with eyes and all mucus membranes.
Concomitant topical acne therapy should be used with caution because a possible cumulative irritancy effect may occur, especially with the use of peeling, desquamating or abrasive agents. If irritation or dermatitis occurs, ERYGEL should be discontinued.
Safety and effectiveness in pediatric patients have not been established.
In clinical trials, the most common adverse events were burning (25%), and occasional peeling, dryness, itching, erythema and oiliness. Irritation of the eyes and tenderness of the skin have also been reported with the topical use of erythromycin.
The contents of ERYGEL are flammable; patients should avoid fire, flame and/or smoking during and immediately following application.
Erygel Topical Gel USP, 2% is indicated for the topical treatment of acne vulgaris.